April 2, 2018 / 12:08 PM / 4 months ago

BRIEF-Biocryst Pharmaceuticals Files Definitive Proxy Statement Related To Pending Merger With Idera Pharmaceuticals

April 2 (Reuters) - Biocryst Pharmaceuticals Inc :

* BIOCRYST PHARMACEUTICALS FILES DEFINITIVE PROXY STATEMENT IN CONNECTION WITH PENDING MERGER WITH IDERA PHARMACEUTICALS

* ‍BIOCRYST SPECIAL MEETING OF STOCKHOLDERS SCHEDULED FOR MAY 9, 2018​

* ‍RECOMMEND THAT ALL CO'S STOCKHOLDERS VOTE "FOR" MERGER PROPOSAL WITH IDERA PHARMA​

* ‍RECOMMEND STOCKHOLDERS VOTE "FOR" BIOCRYST PROPOSALS SET FORTH IN PROXY STATEMENT, INCLUDING "FOR" MERGER PROPOSAL​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below